Paper
0
Immune landscape of isocitrate dehydrogenase-stratified primary and recurrent human gliomas
Authors
Pravesh Gupta,Minghao Dang
Shivangi Oberai,Simona Migliozzi,Rakesh Trivedi,Gayatri Kumar,Mekenzie Peshoff,Nancy Milam,Aml Ahmed,Krishna Bojja,Tuan Tran,Joy Gumin,Carlos Kamiya-Matsuoka,Jason Huse,Kathryn Cox,Jianzhuo Li,Huma Shehwana,Sameer Sheth,Rodriguez Saxon,Baohua Sun,Brittany Kerrigan,Atul Maheshwari,Edwin Parra,Nicholas Navin,Amy Heimberger,Frederick Lang,Antonio Iavarone,Karen Clise-Dwyer,Linghua Wang
+27 authors
,Krishna BhatJournal
Published
Aug 10, 2024
Show more
Save
Tip0
TipSave
Abstract
Human gliomas are classified using isocitrate dehydrogenase (IDH) status as a prognosticator; however, the influence of genetic differences and treatment effects on ensuing immunity remains unclear.
Paper PDF
This paper's license is marked as closed access or non-commercial and cannot be viewed on ResearchHub. Visit the paper's external site.